Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Polycythemia Vera Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Polycythemia Vera Drug market. Detailed analysis of key players, along with key growth strategies adopted by Polycythemia Vera Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
miRagen Therapeutics, Inc
F Hoffmann-La Roche Ltd
PharmaEssentia Corporation
Teva Pharmaceutical Industries Ltd
Novartis AG
Galena Biopharma, Inc
Gilead Sciences, Inc
Karus Therapeutics Limited
Bristol-Myers Squibb Company
Italfarmaco SpA
ANP Technologies, Inc
Nerviano Medical Sciences Srl
By Type:
Dasatinib
Idelalisib
Givinostat
M-009
Others
By End-User:
Clinic
Hospital
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Polycythemia Vera Drug Market
-
1.3 Market Segment by Type
-
1.3.1 China Polycythemia Vera Drug Market Size and Growth Rate of Dasatinib from 2016 to 2027
-
1.3.2 China Polycythemia Vera Drug Market Size and Growth Rate of Idelalisib from 2016 to 2027
-
1.3.3 China Polycythemia Vera Drug Market Size and Growth Rate of Givinostat from 2016 to 2027
-
1.3.4 China Polycythemia Vera Drug Market Size and Growth Rate of M-009 from 2016 to 2027
-
1.3.5 China Polycythemia Vera Drug Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Polycythemia Vera Drug Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.2 China Polycythemia Vera Drug Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.3 China Polycythemia Vera Drug Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Polycythemia Vera Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Polycythemia Vera Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Dasatinib
-
3.4.2 Market Size and Growth Rate of Idelalisib
-
3.4.3 Market Size and Growth Rate of Givinostat
-
3.4.4 Market Size and Growth Rate of M-009
-
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Polycythemia Vera Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Polycythemia Vera Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Polycythemia Vera Drug in Clinic
-
4.4.2 Market Size and Growth Rate of Polycythemia Vera Drug in Hospital
-
4.4.3 Market Size and Growth Rate of Polycythemia Vera Drug in Others
5 Market Analysis by Regions
-
5.1 China Polycythemia Vera Drug Production Analysis by Regions
-
5.2 China Polycythemia Vera Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Polycythemia Vera Drug Landscape Analysis
-
6.1 North China Polycythemia Vera Drug Landscape Analysis by Major Types
-
6.2 North China Polycythemia Vera Drug Landscape Analysis by Major End-Users
7 Central China Polycythemia Vera Drug Landscape Analysis
-
7.1 Central China Polycythemia Vera Drug Landscape Analysis by Major Types
-
7.2 Central China Polycythemia Vera Drug Landscape Analysis by Major End-Users
8 South China Polycythemia Vera Drug Landscape Analysis
-
8.1 South China Polycythemia Vera Drug Landscape Analysis by Major Types
-
8.2 South China Polycythemia Vera Drug Landscape Analysis by Major End-Users
9 East China Polycythemia Vera Drug Landscape Analysis
-
9.1 East China Polycythemia Vera Drug Landscape Analysis by Major Types
-
9.2 East China Polycythemia Vera Drug Landscape Analysis by Major End-Users
10 Northeast China Polycythemia Vera Drug Landscape Analysis
-
10.1 Northeast China Polycythemia Vera Drug Landscape Analysis by Major Types
-
10.2 Northeast China Polycythemia Vera Drug Landscape Analysis by Major End-Users
11 Southwest China Polycythemia Vera Drug Landscape Analysis
-
11.1 Southwest China Polycythemia Vera Drug Landscape Analysis by Major Types
-
11.2 Southwest China Polycythemia Vera Drug Landscape Analysis by Major End-Users
12 Northwest China Polycythemia Vera Drug Landscape Analysis
-
12.1 Northwest China Polycythemia Vera Drug Landscape Analysis by Major Types
-
12.2 Northwest China Polycythemia Vera Drug Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 miRagen Therapeutics, Inc
-
13.1.1 miRagen Therapeutics, Inc Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 F Hoffmann-La Roche Ltd
-
13.2.1 F Hoffmann-La Roche Ltd Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 PharmaEssentia Corporation
-
13.3.1 PharmaEssentia Corporation Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Teva Pharmaceutical Industries Ltd
-
13.4.1 Teva Pharmaceutical Industries Ltd Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Novartis AG
-
13.5.1 Novartis AG Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Galena Biopharma, Inc
-
13.6.1 Galena Biopharma, Inc Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Gilead Sciences, Inc
-
13.7.1 Gilead Sciences, Inc Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Karus Therapeutics Limited
-
13.8.1 Karus Therapeutics Limited Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Bristol-Myers Squibb Company
-
13.9.1 Bristol-Myers Squibb Company Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Italfarmaco SpA
-
13.10.1 Italfarmaco SpA Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 ANP Technologies, Inc
-
13.11.1 ANP Technologies, Inc Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Nerviano Medical Sciences Srl
-
13.12.1 Nerviano Medical Sciences Srl Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Polycythemia Vera Drug Market Size and Growth Rate of Dasatinib from 2016 to 2027
-
Figure China Polycythemia Vera Drug Market Size and Growth Rate of Idelalisib from 2016 to 2027
-
Figure China Polycythemia Vera Drug Market Size and Growth Rate of Givinostat from 2016 to 2027
-
Figure China Polycythemia Vera Drug Market Size and Growth Rate of M-009 from 2016 to 2027
-
Figure China Polycythemia Vera Drug Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Polycythemia Vera Drug Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure China Polycythemia Vera Drug Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Polycythemia Vera Drug Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Polycythemia Vera Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Polycythemia Vera Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Polycythemia Vera Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Polycythemia Vera Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Polycythemia Vera Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Dasatinib
-
Figure Market Size and Growth Rate of Idelalisib
-
Figure Market Size and Growth Rate of Givinostat
-
Figure Market Size and Growth Rate of M-009
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Polycythemia Vera Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Polycythemia Vera Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Others
-
Table China Polycythemia Vera Drug Production by Regions
-
Table China Polycythemia Vera Drug Production Share by Regions
-
Figure China Polycythemia Vera Drug Production Share by Regions in 2016
-
Figure China Polycythemia Vera Drug Production Share by Regions in 2021
-
Figure China Polycythemia Vera Drug Production Share by Regions in 2027
-
Table China Polycythemia Vera Drug Consumption by Regions
-
Table China Polycythemia Vera Drug Consumption Share by Regions
-
Figure China Polycythemia Vera Drug Consumption Share by Regions in 2016
-
Figure China Polycythemia Vera Drug Consumption Share by Regions in 2021
-
Figure China Polycythemia Vera Drug Consumption Share by Regions in 2027
-
Table North China Polycythemia Vera Drug Consumption by Types from 2016 to 2027
-
Table North China Polycythemia Vera Drug Consumption Share by Types from 2016 to 2027
-
Figure North China Polycythemia Vera Drug Consumption Share by Types in 2016
-
Figure North China Polycythemia Vera Drug Consumption Share by Types in 2021
-
Figure North China Polycythemia Vera Drug Consumption Share by Types in 2027
-
Table North China Polycythemia Vera Drug Consumption by End-Users from 2016 to 2027
-
Table North China Polycythemia Vera Drug Consumption Share by End-Users from 2016 to 2027
-
Figure North China Polycythemia Vera Drug Consumption Share by End-Users in 2016
-
Figure North China Polycythemia Vera Drug Consumption Share by End-Users in 2021
-
Figure North China Polycythemia Vera Drug Consumption Share by End-Users in 2027
-
Table Central China Polycythemia Vera Drug Consumption by Types from 2016 to 2027
-
Table Central China Polycythemia Vera Drug Consumption Share by Types from 2016 to 2027
-
Figure Central China Polycythemia Vera Drug Consumption Share by Types in 2016
-
Figure Central China Polycythemia Vera Drug Consumption Share by Types in 2021
-
Figure Central China Polycythemia Vera Drug Consumption Share by Types in 2027
-
Table Central China Polycythemia Vera Drug Consumption by End-Users from 2016 to 2027
-
Table Central China Polycythemia Vera Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Polycythemia Vera Drug Consumption Share by End-Users in 2016
-
Figure Central China Polycythemia Vera Drug Consumption Share by End-Users in 2021
-
Figure Central China Polycythemia Vera Drug Consumption Share by End-Users in 2027
-
Table South China Polycythemia Vera Drug Consumption by Types from 2016 to 2027
-
Table South China Polycythemia Vera Drug Consumption Share by Types from 2016 to 2027
-
Figure South China Polycythemia Vera Drug Consumption Share by Types in 2016
-
Figure South China Polycythemia Vera Drug Consumption Share by Types in 2021
-
Figure South China Polycythemia Vera Drug Consumption Share by Types in 2027
-
Table South China Polycythemia Vera Drug Consumption by End-Users from 2016 to 2027
-
Table South China Polycythemia Vera Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South China Polycythemia Vera Drug Consumption Share by End-Users in 2016
-
Figure South China Polycythemia Vera Drug Consumption Share by End-Users in 2021
-
Figure South China Polycythemia Vera Drug Consumption Share by End-Users in 2027
-
Table East China Polycythemia Vera Drug Consumption by Types from 2016 to 2027
-
Table East China Polycythemia Vera Drug Consumption Share by Types from 2016 to 2027
-
Figure East China Polycythemia Vera Drug Consumption Share by Types in 2016
-
Figure East China Polycythemia Vera Drug Consumption Share by Types in 2021
-
Figure East China Polycythemia Vera Drug Consumption Share by Types in 2027
-
Table East China Polycythemia Vera Drug Consumption by End-Users from 2016 to 2027
-
Table East China Polycythemia Vera Drug Consumption Share by End-Users from 2016 to 2027
-
Figure East China Polycythemia Vera Drug Consumption Share by End-Users in 2016
-
Figure East China Polycythemia Vera Drug Consumption Share by End-Users in 2021
-
Figure East China Polycythemia Vera Drug Consumption Share by End-Users in 2027
-
Table Northeast China Polycythemia Vera Drug Consumption by Types from 2016 to 2027
-
Table Northeast China Polycythemia Vera Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Polycythemia Vera Drug Consumption Share by Types in 2016
-
Figure Northeast China Polycythemia Vera Drug Consumption Share by Types in 2021
-
Figure Northeast China Polycythemia Vera Drug Consumption Share by Types in 2027
-
Table Northeast China Polycythemia Vera Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast China Polycythemia Vera Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Polycythemia Vera Drug Consumption Share by End-Users in 2016
-
Figure Northeast China Polycythemia Vera Drug Consumption Share by End-Users in 2021
-
Figure Northeast China Polycythemia Vera Drug Consumption Share by End-Users in 2027
-
Table Southwest China Polycythemia Vera Drug Consumption by Types from 2016 to 2027
-
Table Southwest China Polycythemia Vera Drug Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Polycythemia Vera Drug Consumption Share by Types in 2016
-
Figure Southwest China Polycythemia Vera Drug Consumption Share by Types in 2021
-
Figure Southwest China Polycythemia Vera Drug Consumption Share by Types in 2027
-
Table Southwest China Polycythemia Vera Drug Consumption by End-Users from 2016 to 2027
-
Table Southwest China Polycythemia Vera Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Polycythemia Vera Drug Consumption Share by End-Users in 2016
-
Figure Southwest China Polycythemia Vera Drug Consumption Share by End-Users in 2021
-
Figure Southwest China Polycythemia Vera Drug Consumption Share by End-Users in 2027
-
Table Northwest China Polycythemia Vera Drug Consumption by Types from 2016 to 2027
-
Table Northwest China Polycythemia Vera Drug Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Polycythemia Vera Drug Consumption Share by Types in 2016
-
Figure Northwest China Polycythemia Vera Drug Consumption Share by Types in 2021
-
Figure Northwest China Polycythemia Vera Drug Consumption Share by Types in 2027
-
Table Northwest China Polycythemia Vera Drug Consumption by End-Users from 2016 to 2027
-
Table Northwest China Polycythemia Vera Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Polycythemia Vera Drug Consumption Share by End-Users in 2016
-
Figure Northwest China Polycythemia Vera Drug Consumption Share by End-Users in 2021
-
Figure Northwest China Polycythemia Vera Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of miRagen Therapeutics, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of miRagen Therapeutics, Inc
-
Figure Sales and Growth Rate Analysis of miRagen Therapeutics, Inc
-
Figure Revenue and Market Share Analysis of miRagen Therapeutics, Inc
-
Table Product and Service Introduction of miRagen Therapeutics, Inc
-
Table Company Profile and Development Status of F Hoffmann-La Roche Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffmann-La Roche Ltd
-
Figure Sales and Growth Rate Analysis of F Hoffmann-La Roche Ltd
-
Figure Revenue and Market Share Analysis of F Hoffmann-La Roche Ltd
-
Table Product and Service Introduction of F Hoffmann-La Roche Ltd
-
Table Company Profile and Development Status of PharmaEssentia Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of PharmaEssentia Corporation
-
Figure Sales and Growth Rate Analysis of PharmaEssentia Corporation
-
Figure Revenue and Market Share Analysis of PharmaEssentia Corporation
-
Table Product and Service Introduction of PharmaEssentia Corporation
-
Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd
-
Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd
-
Table Company Profile and Development Status of Novartis AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG
-
Figure Sales and Growth Rate Analysis of Novartis AG
-
Figure Revenue and Market Share Analysis of Novartis AG
-
Table Product and Service Introduction of Novartis AG
-
Table Company Profile and Development Status of Galena Biopharma, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galena Biopharma, Inc
-
Figure Sales and Growth Rate Analysis of Galena Biopharma, Inc
-
Figure Revenue and Market Share Analysis of Galena Biopharma, Inc
-
Table Product and Service Introduction of Galena Biopharma, Inc
-
Table Company Profile and Development Status of Gilead Sciences, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences, Inc
-
Figure Sales and Growth Rate Analysis of Gilead Sciences, Inc
-
Figure Revenue and Market Share Analysis of Gilead Sciences, Inc
-
Table Product and Service Introduction of Gilead Sciences, Inc
-
Table Company Profile and Development Status of Karus Therapeutics Limited
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Karus Therapeutics Limited
-
Figure Sales and Growth Rate Analysis of Karus Therapeutics Limited
-
Figure Revenue and Market Share Analysis of Karus Therapeutics Limited
-
Table Product and Service Introduction of Karus Therapeutics Limited
-
Table Company Profile and Development Status of Bristol-Myers Squibb Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company
-
Table Product and Service Introduction of Bristol-Myers Squibb Company
-
Table Company Profile and Development Status of Italfarmaco SpA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Italfarmaco SpA
-
Figure Sales and Growth Rate Analysis of Italfarmaco SpA
-
Figure Revenue and Market Share Analysis of Italfarmaco SpA
-
Table Product and Service Introduction of Italfarmaco SpA
-
Table Company Profile and Development Status of ANP Technologies, Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ANP Technologies, Inc
-
Figure Sales and Growth Rate Analysis of ANP Technologies, Inc
-
Figure Revenue and Market Share Analysis of ANP Technologies, Inc
-
Table Product and Service Introduction of ANP Technologies, Inc
-
Table Company Profile and Development Status of Nerviano Medical Sciences Srl
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nerviano Medical Sciences Srl
-
Figure Sales and Growth Rate Analysis of Nerviano Medical Sciences Srl
-
Figure Revenue and Market Share Analysis of Nerviano Medical Sciences Srl
-
Table Product and Service Introduction of Nerviano Medical Sciences Srl
-
